Treatment Invest Information

Earnings
Aura Biosciences Reveals Encouraging Phase 2 Outcomes for Bel-sar as a Primary Treatment in Battling Early-Stage Choroidal Melanoma Sep 13, 2024
Pharmaceuticals
FDA Grants Approval to Arcutis' Novel ZORYVE® Cream for Atopic Dermatitis Patients Jul 10, 2024
Companies
FDA Approves Lilly's Kisunla™ for Early Symptomatic Alzheimer's Jul 3, 2024
Healthcare
New Research Suggests Less Intensive Cancer Treatments Yield Comparable Outcomes Jun 3, 2024
Companies
Immix Biopharma Receives EU Orphan Drug Designation for NXC-201 in Multiple Myeloma Apr 29, 2024
Investment
SciSparc Ltd. Embarks on Transformative Phase IIb Trial for Tourette Syndrome Using THC-Based Medication Nov 11, 2023
Pasithea Therapeutics Advances ALS Treatment with New Lead Candidate PAS-003 Targeting α5β1 Integrin Nov 9, 2023
GH Research Advances Clinical Trials for GH001 in the Fight Against Treatment-Resistant Depression Nov 9, 2023
PharmAla Begins Groundbreaking Observational Trial for Real-World Efficacy of MDMA Therapy Nov 9, 2023